Abstract: An electronic device is disclosed and includes a substrate, a circuit layer, and a plurality of diodes. The substrate has a plurality of structures. The circuit layer is disposed on the substrate. The diodes are disposed on the circuit layer, wherein a first spacing is defined as a distance between a center point of a first one of the structures and a center point of a second one of the structures, a second spacing is defined as a distance between a center point of a third one of the structures and a center point of a fourth one of the structures, and an absolute value of a difference between the first spacing and the second spacing is less than 0.5 times radius of curvature of the electronic device when the electronic device is bent.

Abstract: This application is directed to frequency controlling in an electronic device that includes a selector, a clock generated, and a controller. The selector selects one of a first reference signal and a second reference signal as an input signal having an input phase. The clock generator receives the input signal and generates a periodic signal, and the periodic signal has an output phase that matches the input phase of the input signal. While the first reference signal is selected as the input signal, the controller identifies a temporal range including a peak instant at which the second reference signal reaches a peak frequency, select a switching instant within the temporal range based on a known temporal position of the peak instant with respect to the temporal range, and control the selector to select the second reference signal as the input signal at the switching instant.

Abstract: This application is directed to frequency controlling in an electronic device (e.g., a retimer of a data link). The electronic device includes a selector, a clock generated, and a controller. The selector selects one of a first reference signal and a second reference signal as an input signal having an input phase. The clock generator receives the input signal and generates a periodic signal with reference to the input signal, and the periodic signal has an output phase that matches the input phase of the input signal. While the first reference signal is selected as the input signal, the controller determines whether the second reference signal is in a temporal range in which the second reference signal reaches a peak frequency and controls the selector to select the second reference signal as the input signal in accordance with a determination that the second reference signal is in the temporal range.

Abstract: A mini cutting bit includes a shank and a cutting part. The cutting part has a first spiral portion and a second spiral portion parallelly and twistedly formed thereon. The cutting part further has two chip removal flutes between the first and the second spiral portions. The first spiral portion has a first chip breaking flute on a top thereof while the second spiral portion has a second chip breaking flute. Widths of the first and the second chip breaking flutes are smaller than that of the tops of the first and the second spiral portions respectively.

Abstract: A mini cutting bit includes a shank, a cutting part and a bit tip, wherein the cutting part has opposite ends connected to the shank and the bit tip. The bit tip and the cutting part are made of different materials, and the bit tip is harder than the cutting part.

Abstract: A system includes an illumination source and an imaging apparatus that includes an electronic rolling shutter imager and is configured for sequentially resetting rows of pixels of the rolling shutter imager from a first row to a last row, sequentially reading charge accumulated at the rows of pixels from the first row to the last row, wherein the first row is read after resetting the last row, controlling the illumination source to illuminate the tissue of the subject with illumination light for an illumination period that lasts longer than a vertical blanking period, wherein the vertical blanking period is the period from the resetting of the last row to the reading of the first row, and generating an image frame from the readings of charge accumulated at the rows of pixels, wherein at least one reading of charge accumulated at a row of pixels is removed or replaced.

Abstract: Disclosed is a pharmaceutical composition containing dabigatran etexilate and a preparation method thereof. The pharmaceutical composition comprises a pharmaceutically active ingredient, dabigatran etexilate and/or dabigatran etexilate mesylate, an amphiphilic polymer of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer, and a hydrophilic polymer of polyoxyethylene-polyoxypropylene glycol block copolymer. The mass percentage of the active pharmaceutical ingredient in the pharmaceutical composition is 5 wt % to 60 wt %; the mass percentage of the amphiphilic polymer in the pharmaceutical composition is 3 wt % to 40 wt %; and the mass percentage of the hydrophilic polymer in the pharmaceutical composition is 10 wt % to 90 wt %. The pharmaceutical composition not only increases the bioavailability of the pharmaceutically active ingredient, but also reduces absorption variability, and provides a more stable concentration of dabigatran in plasma, thereby reducing adverse side effects.

Abstract: A solid particle, a preparation method therefor, and a pharmaceutical composition. The solid particle comprises a porous solid particle and a non-aqueous liquid formula. The non-aqueous liquid formula comprises 0.10-4.00 wt % of a hydrophobic active pharmaceutical agent, 28.00-99.90 wt % of a hydrophobic solubilizing solution, 0-70.00 wt % of a non-ionic surfactant, and 0-1.00 wt % of an antioxidant. The hydrophobic solubilizing solution comprises a medium-chain monoglyceride and diglyceride, and/or a propylene glycol fatty acid monoester.

Abstract: Disclosed are a pharmaceutical composition, an osmotic pump controlled-release drug delivery system comprising the pharmaceutical composition and a preparation method therefor. The pharmaceutical composition comprises a tablet core and a coating film. The tablet core comprises a drug-pulling layer, and the coating film comprises 50-90 wt % of cellulose acetate and 10-50 wt % of Copovidone. The Copovidone can be obtained by means of the polymerization of vinyl pyrrolidone and vinyl acetate in a molar ratio of 40:60-80:20.

Abstract: A method of transmitting data and command through an RS232 serial port incorporated with a user-end device and a server-end device connected through the RS232 serial port is disclosed and includes following steps: accumulating a value of a first counter of the user-end device and a value of a second counter of the server-end device whenever a data is transmitted from the server-end device to the user-end device; controlling the server-end device to stop transmitting the data and to wait when both of the two values reach a triggering threshold; controlling the user-end device to transmit a control command to the server-end device through the RS232 serial port while the server-end device is waiting; and, resetting the first and the second counter and controlling the server-end device to restore to transmit the data to the user-end device after a waiting time is elapsed.

Abstract: An electronic apparatus includes a housing, a first light emitting array and a second light emitting array. The first light emitting array includes first light-emitting units disposed in a first left region and a second left region. The second light emitting array is disposed adjacent to the first light emitting array. The second light emitting array includes second light-emitting units disposed in a first right region and a second right region. The difference between the average brightness in the first left region and the average brightness in the first right region is in a range from 0% to 20%, and the difference between the average brightness in the second left region and the average brightness in the second right region is less than the difference between the average brightness in the first left region and the average brightness in the first right region.

Abstract: A method of imaging tissue of a subject using an electronic rolling shutter imager includes sequentially resetting rows of pixels of the rolling shutter imager from a first row to a last row for a first amount of time; illuminating the tissue of the subject with illumination light over an illumination period that begins once the last row of the rolling shutter imager has been reset and lasts for at least the first amount of time; accumulating charge at the rows of pixels over at least the illumination period based on light that is received from the tissue of the subject while the tissue of the subject is illuminated with the illumination light; sequentially reading charge accumulated at the rows of pixels from the first row to the last row once the illumination period has ended; and generating an image frame from the rows of pixels.

Abstract: The present invention provides a pharmaceutical composition for treating chronic stroke, involving injection via brain into the cranium of a patient having chronic stroke for six months or more; the pharmaceutical composition is a suspension at least comprising TS stem cells, an active synergistic component and a growth factor, wherein the expression level of CD34 and CD45 of the TS stem cells is 10% or less, and the expression level of CD90 and CD105 is 90% or more; the active synergistic component is an extracellular vesicle; the growth factor is at least one selected from the group consisting of HGF, G-CSF, Fractalkine, IP-10, EGF, IL-1?, IL-1?, IL-4, IL-5, IL-13, IFN?, TGF? and sCD40L. The present invention overcomes the limitations of previous cell therapy and provides a cell-based preparation that is clinically safe and therapeutically effective for chronic cerebral stroke.

Abstract: Disclosed is a pharmaceutical composition containing dabigatran etexilate and a preparation method thereof. The pharmaceutical composition comprises a pharmaceutically active ingredient, dabigatran etexilate and/or dabigatran etexilate mesylate, and a amphiphilic polymer of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer. The mass ratio of the two is 1:0.23 to 1:3. The pharmaceutical composition not only increases the bioavailability of the pharmaceutically active ingredient, but also reduces absorption variability, and provides a more stable concentration of dabigatran in plasma, thereby reducing adverse side effects.

Abstract: A magnetic attraction structure for a wireless charging device or a terminal device is provided, which includes one or more electromagnets. The electromagnet includes an iron core and a winding group. The iron core includes a first plate, a second plate and a connecting part. The first plate is separated from the second plate by a distance, and the connecting part is connected between the first plate and the second plate, and the winding group surrounds the connecting part. A side surface of a long side of the first plate and a side surface of a long side of the second plate are configured to face a cover plate of the wireless charging device or a cover plate of the terminal device. A wireless charging device including the above-mentioned magnetic attraction structure is also provided.

Abstract: A packet forwarding apparatus includes a first storage device and a processor. The first storage device has a plurality of buffers allocated therein, and at least one buffer included in the plurality of buffers is arranged to buffer at least one packet. The processor is arranged to execute a Linux kernel to perform software-based packet forwarding associated with the at least one packet. The at least one buffer allocated in the first storage device is recycled through direct memory access (DMA) management, and is reused for buffering at least one other packet.

Abstract: The present application discloses a thermal insulation coating and a method for applying the same. Raw materials for preparing the thermal insulation coating includes PVDF resin, water-based epoxy resin solution, hollow glass microbead, ytterbium modified nano-powder, diluent, polyvinyl alcohol, titanium dioxide powder, rare earth, negative ion powder, and leveling agent.

Abstract: A method of imaging tissue of a subject using an electronic rolling shutter imager includes sequentially resetting rows of pixels of the rolling shutter imager from a first row to a last row, sequentially reading charge accumulated at the rows of pixels from the first row to the last row, wherein the first row is read after resetting the last row, illuminating the tissue of the subject with illumination light for an illumination period that lasts longer than a vertical blanking period, wherein the vertical blanking period is the period from the resetting of the last row to the reading of the first row, and generating an image frame from the readings of charge accumulated at the rows of pixels, wherein at least one reading of charge accumulated at a row of pixels is removed or replaced to generate the image frame.

Abstract: An electronic device is disclosed and includes a substrate, a circuit layer, and a plurality of diodes. The substrate has a plurality of structures. The circuit layer is disposed on the substrate. The diodes are disposed on the circuit layer, wherein a first spacing is defined as a distance between a center point of a first one of the structures and a center point of a second one of the structures, a second spacing is defined as a distance between a center point of a third one of the structures and a center point of a fourth one of the structures, and an absolute value of a difference between the first spacing and the second spacing is less than 0.5 times radius of curvature of the electronic device when the electronic device is bent.

Abstract: A heat cycle system and a control method. The heat cycle system includes: driving devices, one or a plurality of outdoor units, and a plurality of indoor units, which are connected by pipelines; a bypass pipeline for the plurality of indoor units, a bypass valve being disposed in the bypass pipeline; a pressure sensor that senses a pressure difference ?Po across the plurality of outdoor units; and a controller that is preset with a pressure difference set value ?Pset, wherein the controller calculates a pressure offset parameter ?P=?Po??Pset and adjusts an opening degree of the bypass valve based on the pressure offset parameter ?P so that the pressure offset parameter ?P approaches zero, and wherein the controller is preset with a first pressure offset threshold P1, and the controller is configured such that closed indoor units enter a bypass mode one by one when ?P>P1, until ?P?P1.